CompletedNot Applicable

Replication Study to Analyze the Surgical Treatment of Proximal Humeral Fracture

32,953 participantsStarted 2011-01-01

Plain-language summary

The study at hand aimed to analyze the replicability of the observed treatment effects in these studies published by Koeppe et al. and Stolberg-Stolberg et al.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- all patients will be included, who had an inpatient coded treatment using LPF or RTSA Exclusion Criteria: * Incomplete insurance status within two years before index * Incomplete basic information * Age\<65 years * Missing diagnosis of PHF (ICD: S42.2) within two years before surgery * Previous surgical treatment (RTSA, LPF or other fracture fixation) * Coded polytrauma * Bone tumors/ bone metastasis * Both sides or missing information of surgery side * COVID-19 infection during index hospitalization

What they're measuring

30-day mortality

Timeframe: 30 days

Overall survival (OS)

Timeframe: up to 12 years

Major adverse events during index case

Timeframe: through hospital stay, an average of 16 days

Major adverse events after discharge

Timeframe: up to 12 years

Thromboembolic events during index

Timeframe: through hospital stay, an average of 16 days

Thromboembolic events (or death) after discharge

Timeframe: up to 12 years

Surgical complications during index case

Timeframe: through hospital stay, an average of 16 days

Surgical complications after discharge

Timeframe: up to 12 years

Trial details

NCT IDNCT06537024

SponsorUniversity Hospital Muenster

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-30

View on ClinicalTrials.gov More Proximal Humeral Fracture trials